Amsterdam, the Netherlands –Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced it has entered into an agreement to acquire SpectraWAVE, Inc., an innovator in ...

One-year success rates from angioplasty procedures to open clogged arteries in the legs were significantly higher among patients whose procedures were guided by intravascular ultrasound (IVUS) ...

Philips has agreed to acquire SpectraWAVE, a Massachusetts-based medical device company focused on technologies to help diagnose and guide treatment for patients with coronary artery disease.

The MarketWatch News Department was not involved in the creation of this content. --Primary safety and effectiveness endpoints were met with 98% clinical success rate and 100% angiographic success in ...

DUBLIN--(BUSINESS WIRE)--The "Intravascular Ultrasound (IVUS) - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The report provides separate comprehensive ...

PARIS--(BUSINESS WIRE)--Elixir Medical, a developer of transformative technologies to treat cardiovascular and peripheral disease, today announced that the PINNACLE I study evaluating the safety and ...